$31.46
$68.52
bear $31.46
base $50.59
bull $68.52
margin of safety $30.00
market price* $85.86
Ventas owns about 1,400 senior housing communities, medical office and outpatient buildings and life science space across the United States, Canada and the United Kingdom. The largest and fastest-growing piece is senior housing that Ventas now operates through third-party managers (its "SHOP" segment): it collects resident rent and pays the operating costs, so it keeps the upside when occupancy and prices rise and the downside when wages and other costs rise. Smaller pieces are properties leased under long-term triple-net leases (the Ardent hospital and Kindred portfolios among them) and medical and research office buildings. What the business earns. We measure the cash the properties produce before paying lenders, after stock compensation and after the recurring capital spending needed to keep buildings competitive. That figure was $1.82 billion in 2025, up from $1.57 billion in 2024, $1.45 billion in 2023, $1.39 billion in 2022 and $1.26 billion in 2021, the pandemic trough; it was $1.70 billion in 2019 and $1.59 billion in 2020 before occupancy collapsed. We do not deduct acquisitions or the roughly $280 million a year of ground-up development as ongoing costs, since those add new earnings; of the $364 million recurring capital line in 2025 we treated about $42 million as growth-related and the rest as maintenance. Ventas pays its lenders about $580 million of cash interest a year, which is why the shares are worth the business less the debt. Why per-share history is not the guide. Ventas funds acquisitions largely by issuing shares: the weighted share count rose from 348 million in 2016 to 463 million in 2025, and shares outstanding were 513 million on June 30, 2026, after about $2.5 billion of stock was issued in the first half of 2026. So we value total business cash and divide by today's shares and today's debt, which makes the 2025 full-year level the right starting point; earlier years describe a smaller portfolio. The first half of 2026 supports it: operating cash flow was $951 million against $796 million a year earlier, up 19%, helped by acquisitions already closed and by the Brookdale properties converting from fixed rent into Ventas-operated senior housing (65 properties stay on a lease extended to 2035; 45 converted; 11 sold or held for sale). Business cash flow grew 15.8% in 2025; the base case assumes 12% in 2026, below that pace, because first-half results already show roughly that level from acquisitions that have closed and been paid for. Debt. Ventas owed $12.77 billion at June 30, 2026 against $0.2 billion of cash and $0.05 billion owed to minority partners. The debt costs about 4.95% on average, below what new borrowing would cost, which is worth roughly $0.4 billion, so we count net obligations at $12.2 billion in the base and bull cases. Maturities are spread out ($0.7 billion in the second half of 2026, $0.9 billion in 2027, $1.5 billion in 2028, $2.2 billion in 2029, $1.4 billion in 2030, $6.0 billion later), with no single year large enough to force an asset sale. Bear case: $31 a share. The business is worth about $29.7 billion, it owes about $12.8 billion, leaving $16.9 billion. We assume the 2026 gains hold but nothing more in 2027, then a repeat of the 2020 to 2021 senior housing shock, when this business's cash flow fell about 26% from 2019 to 2021: here a labor-cost and occupancy squeeze cuts cash flow 13% in 2028 and 26% from the 2027 level in 2029, followed by only 5% annual recovery to 94% of the earlier peak by 2035, with no growth after that. We add refinancing 2027 to 2029 maturities at about 7.5% and 4.4% more shares, the dilution seen in 2019 to 2021. Cash flow at the trough is about $1.45 billion against roughly $650 million of interest, so the debt can be carried. Base case: $51 a share. The business is worth about $38.2 billion, it owes $12.2 billion, leaving $26.0 billion. Cash flow rises 12% in 2026, 3% in 2027 as acquisitions finish contributing a full year, then 1.5% a year to 2035 from contractual rent escalators and price increases that offset cost inflation, then stays flat because the buildings continue to earn rent so long as maintenance spending, which we deduct every year, continues. We left out further acquisitions and development, because they have been paid for with new shares and so far have not raised per-share earnings, and any margin gains from higher occupancy, which are not locked in. Bull case: $69 a share. The business is worth about $47.4 billion, it owes $12.2 billion, leaving $35.2 billion. Cash flow grows 15% in 2026 (the 2025 pace, which first-half 2026 matches), then 8%, 6%, 5% and 4% as occupancy and room rates keep rising as they have every year since 2021, and 3% a year through 2035, then flat. What could break this. We tested the starting level against recurring capital spending, which rose to 6.2% of revenue in 2025 versus a ten-year average of 4.65%; had we used the higher rate on 2026 revenue it would reduce the starting cash flow by about 5%, which the below-trend 12% growth assumption already absorbs. Two items could not be reconciled from the available filings: the second-quarter 2026 report text (only its figures) and any acquisitions or stock issuance agreed after June 30. Earnings are also sensitive to the Brookdale conversions, which move Ventas from collecting rent to bearing operating costs. Change since the last analysis. Our September estimates were $24, $40 and $63; they were built on a different earnings definition and share base and are not comparable. What changed in the business: first-half 2026 cash flow is up 19%, shares outstanding rose about 8% in six months, debt fell $0.3 billion, and the Brookdale conversions took effect. Margin-of-safety price: $30. We are fairly sure of the 2025 level, since cash flow has risen in each of the last four years and first-half 2026 confirms it, but the shares own 68% of the business after $12 billion of debt, so a 10% change in business value moves the shares about 15%. The worst plausible outcome, a pandemic-sized hit to senior housing occupancy coinciding with wage inflation, is modeled in the bear case; outcomes it does not model include cuts to Medicaid payments that squeeze the hospital and nursing tenants, and a shut credit market while $4.7 billion matures from 2027 to 2029. The structure would survive both, since interest is covered about two times even at the bear-case trough and no single year's maturity is large. If we are wrong about growth and the business merely holds its 2025 level, the shares would be worth roughly $35; if cash flow slipped 15% below that, about $26. The price assumes a holding period of three years, with roughly $2.10 a year in dividends (about 70% of 2025 cash earnings after stock compensation and maintenance), and from $30 flat 2025-level earnings plus dividends imply about 15% a year and the base case more than 20%.